Previous study reported that HNF4α could prevent liver steatosis by controlling hepatic carboxylesterase 2 expression and modulating lipolysis, lipogenesis, and endoplasmic reticulum in NAFLD [36]. The gene discussed is CES2; the disease is metabolic dysfunction-associated steatotic liver disease.